DENVER, Sept. 18, 2017 -- Two-time Super Bowl Champion and All-Pro for the New York Giants Leonard Marshall has been nominated for the NFL Hall of Fame.
Videos accompanying this announcement are available at: http://www.globenewswire.com/NewsRoom/AttachmentNg/e969a109-845a-4abc-aa62-2fcc96f11a1e
http://www.globenewswire.com/NewsRoom/AttachmentNg/7b17c29c-2346-4e3a-86bf-e7efc228eb66
http://www.globenewswire.com/NewsRoom/AttachmentNg/8b88b463-0128-45d3-961d-485c8f882c38
Leonard’s storied NFL career is matched only by his post-football commitment to contribute positively to the lives of others, particularly children and other football players at all levels.
This nomination is also notable because Marshall is the first hemp cannabidiol advocate to be nominated to the NFL Hall of Fame.
As a founder of multiple nonprofits and a volunteer for hundreds more, Marshall has made philanthropy and advocacy his post-NFL career. As a C.T.E. survivor, one of Marshall’s passions is serving as a player advocate to ensure that former and current NFL players have access to hemp-based cannabidiol (CBD), a neuroprotective and anti-inflammatory. Diagnosed with C.T.E. in 2003, Marshall was one of the first living NFL players to receive this diagnosis.
“We’re incredibly proud of Leonard’s accomplishments – he is truly a warrior – as a player and a C.T.E. survivor. We’re delighted to see him nominated to the Football Hall of Fame, a fitting recognition of his football career,” said Gabriel Ettenson, Elixinol COO.
From this year’s nominees, 18 finalists will be presented to the Professional Hall of Fame’s Selection Committee, which will determine the final five in February 2018. The 48-member Selection Committee then votes yes or no on each of the final five. To be enshrined in the Hall of Fame, a finalist must receive at least 80% yes votes. [Editor’s note: See http://www.profootballhof.com/heroes-of-the-game/selection-process-faq/ for details on the selection process.]
About Elixinol:
Colorado-based Elixinol, founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the world’s most influential CBD brands. With a proven track record of growing and manufacturing high-quality hemp, Elixinol also conducts rigorous laboratory testing and quality control. A global leader in hemp distribution, Elixinol distributes CBD products in 27 countries including the United States, Japan, Puerto Rico, Brazil and throughout Europe. More information is available at Elixinol.com.
Media Contact:
Chris Husong
Elixinol
+1 844-804-3504 ext 420
[email protected]


TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 



